Award
National Cancer Institute 11446408
Antigen immunodominance in regulation of anti-tumor CD8 T cell immunity and immunotherapy response
Recipient
Oregon Health & Science University
Award Amount
$638,532.00
Ceiling
$638,532.00
Awarded
July 10, 2026
Identifier
11446408
NIH grant awarded to Oregon Health & Science University for research on antigen immunodominance in anti-tumor CD8 T cell immunity and immunotherapy response, with a focus on cancer immunotherapy using preclinical models and advanced technologies.
Description
This is a NIH grant project focused on cancer immunotherapy, specifically on antigen immunodominance and T cell responses in cancer. The project involves preclinical mouse models and advanced single-cell technologies. The funding is provided by the National Cancer Institute (NCI).